Recent

% | $
Quotes you view appear here for quick access.

Pain Therapeutics Inc. Message Board

  • ladimona252xx ladimona252xx Aug 16, 2013 4:17 PM Flag

    hello 6$ at least...?

    Disclosure: I am long DRRX. (More...)

    Pfizer (PFE) has filed a new clinical trial this week for its drug candidate PF-00345439. We believe a long position in DRRX or PTIE may be warranted based on this development as outlined herein.

    A quick check of previous clinical trials shows that this internal identifier refers to Remoxy, the abuse-resistant oxycodone formulation developed originally by Durect Corporation (DRRX), licensed to Pain Therapeutics (PTIE) and partnered to PFE ((see image below).
    430 people received this article by email alert
    Add your email to get alerts on PTIE too:
    Get email alerts on PTIE »

    (click to enlarge)

 
PTIE
1.89+0.13(+7.39%)Jul 31 4:00 PMEDT